Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jonah A. Hoyt
Observed names:
J A Hoyt,
J. A. Hoyt,
Jonah A Hoyt,
Jonah Hoyt
Institution:
Endeavor Health
Observed institutions:
Brigham and Women's Hospital,
Endeavor Health
OpenAlex ID:
A5113571668
Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures
2006
·
C M Mack
, C X Moore
, et al.
·
International Journal of Obesity
·
152
A novel long‐acting glucose‐dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents
2013
·
K. Tatarkiewicz
, D. M. Hargrove
, et al.
·
Diabetes Obesity and Metabolism
·
36
PDF
A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes
2024
·
Jonah A. Hoyt
, Emily Cozzi
, et al.
·
Diabetes Obesity and Metabolism
·
21
PDF
Patient Education Reduces Rates Of Dka For Populations On Sglt2i
2025
·
Jonah A Hoyt
, Elena S Gross
, et al.
·
Journal of the Endocrine Society
PDF
Author response for "A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes"
2024
·
Jonah A. Hoyt
, Emily Cozzi
, et al.
·
Publons reviews and discussion
Is Euglycemic Diabetic Ketoacidosis an Underrecognized Risk of SGLT2 Inhibitor Utilization?
2022
·
Romy Block
, Polina Imas
, et al.
·
Journal of the Endocrine Society
PDF
Show more works
View as search
Works count:
6
Citation count:
209
H-index:
3
I10-index:
3
Year
Topic
Type